Property | Value |
?:abstract
|
-
BACKGROUND: There are limited data on Coronavirus disease 2019 (COVID-19) in solid organ transplant patients, especially in heart transplant recipients, with only a few case reports and case series described so far. Heart transplant recipients may be at particular high risk due to their comorbidities and immunosuppressed state. CASE PRESENTATION: This report describes the clinical course and the challenging management of early COVID-19 infection in two heart transplant recipients who tested positive for the SARS-CoV-2 virus in the perioperative period of the transplant procedure. The two patients developed a severe form of the disease and ultimately died despite the initiation of an antiviral monotherapy with hydroxychloroquine coupled with the interruption of mycophenolate mofetil. CONCLUSIONS: These two cases illustrate the severity and poor prognosis of COVID-19 in the perioperative period of a heart transplant. Thorough screening of donors and recipients is mandatory, and the issue of asymptomatic carriers needs to be addressed. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12879-021-05793-6.
|
?:creator
|
|
?:doi
|
|
?:doi
|
-
10.1186/s12879-021-05793-6
|
?:journal
|
|
?:license
|
|
?:pdf_json_files
|
-
document_parses/pdf_json/0d22cd81bf8835d1affa5520923e5fdd3ad675e4.json
|
?:pmc_json_files
|
-
document_parses/pmc_json/PMC7816134.xml.json
|
?:pmcid
|
|
?:pmid
|
|
?:pmid
|
|
?:publication_isRelatedTo_Disease
|
|
?:sha_id
|
|
?:source
|
|
?:title
|
-
Clinical course and challenging management of early COVID-19 infection after heart transplantation: case report of two patients
|
?:type
|
|
?:year
|
|